[Clinical test of the therapeutic effectiveness of hepatic opotherapy associated with high doses of nucleosides].
D000328:Adult; D000368:Aged; D000740:Anemia / Q000188:drug therapy; D001247:Asthenia / Q000188:drug therapy*; D001835:Body Weight / Q000187:drug effects; D002100:Cachexia / Q000188:drug therapy; D002908:Chronic Disease; D003562:Cytidine / Q000008:administration & dosage; D048909:Diabetes Complications; D005260:Female; D006331:Heart Diseases / Q000150:complications; D006801:Humans; D006980:Hyperthyroidism / Q000150:complications; D008107:Liver Diseases / Q000188:drug therapy*; D008110:Liver Extracts / Q000008:administration & dosage*; D008297:Male; D008875:Middle Aged; D009705:Nucleosides / Q000008:administration & dosage*; D014529:Uridine / Q000008:administration & dosage; D014805:Vitamin B 12 / Q000008:administration & dosage
D008110:Liver Extracts; D009705:Nucleosides; D003562:Cytidine; D014805:Vitamin B 12; D014529:Uridine
Esperienze cliniche sull'efficacia terapeutica dell'opoterapia epatica associata con nucleosidi ad alte dosi.